NovX Systems Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

NovX Systems General Information

Description

Developer of EMR software designed for pain and addiction clinics in Canada. The company develops drug-screening devices designed to be used in non-laboratory settings by non-technical operators, helping clinics improve efficiency by eliminating time-consuming, redundant steps with intuitive, single-click, prompted inputs.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 9133 Leslie Street
  • Suite 200
  • Richmond Hill, Ontario L4B 4N1
  • Canada
+1 (905)
Primary Industry
Monitoring Equipment
Other Industries
Other Devices and Supplies
Parent Company
Vertical(s)
Corporate Office
  • 9133 Leslie Street
  • Suite 200
  • Richmond Hill, Ontario L4B 4N1
  • Canada
+1 (905)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NovX Systems Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 06-Mar-2014 Completed Generating Revenue
6. Later Stage VC (Series C) 02-May-2008 Completed Generating Revenue
5. Later Stage VC 20-Jul-2007 Completed Generating Revenue
4. Later Stage VC (Series B) 11-Aug-2006 Completed Generating Revenue
3. Later Stage VC 01-Apr-2006 Completed Generating Revenue
2. Early Stage VC (Series B) 16-Mar-2005 $6.39M $6.39M Completed Generating Revenue
1. Early Stage VC (Series A) 01-Jun-2001 Completed Product Development
To view NovX Systems’s complete valuation and funding history, request access »

NovX Systems Patents

NovX Systems Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2008109977-A1 Method of compensation of dose-response curve of an assay for sensitivity to perturbing variables Inactive 12-Mar-2007
US-20070202010-A1 Microplate assay kit Inactive 28-Feb-2006
WO-2007098576-A1 Microplate assay kit Inactive 28-Feb-2006
CA-2504559-A1 Dye solubilization binding assay Inactive 20-Apr-2005
EP-1866653-A1 Automated analyzer Inactive 07-Mar-2005 G01N35/0092
To view NovX Systems’s complete patent history, request access »

NovX Systems Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Celtic House Venture Partners Venture Capital Minority
GF Private Equity Group Fund of Funds Minority
Kalkhoven, Pettit, Levin & Johnson Ventures Venture Capital Minority
MMV Capital Partners Growth/Expansion Minority
Presidio Partners Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

NovX Systems FAQs

  • When was NovX Systems founded?

    NovX Systems was founded in 2001.

  • Where is NovX Systems headquartered?

    NovX Systems is headquartered in Richmond Hill, Canada.

  • What industry is NovX Systems in?

    NovX Systems’s primary industry is Monitoring Equipment.

  • Is NovX Systems a private or public company?

    NovX Systems is a Private company.

  • What is NovX Systems’s current revenue?

    The current revenue for NovX Systems is .

  • How much funding has NovX Systems raised over time?

    NovX Systems has raised $22.1M.

  • Who are NovX Systems’s investors?

    Celtic House Venture Partners, GF Private Equity Group, Kalkhoven, Pettit, Levin & Johnson Ventures, MMV Capital Partners, and Presidio Partners are 5 of 7 investors who have invested in NovX Systems.

  • When was NovX Systems acquired?

    NovX Systems was acquired on 06-Mar-2014.

  • Who acquired NovX Systems?

    NovX Systems was acquired by Qvella.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process